COST-EFFECTIVENESS OF CARDIAC RESYNCHRONISATION THERAPY FOR PATIENTS WITH MODERATE-TO-SEVERE HEART FAILURE

被引:0
|
作者
Neyt, M. [1 ]
Stroobandt, S. [1 ]
Obyn, C. [1 ]
Camberlin, C. [1 ]
Devriese, S. [1 ]
De Laet, C. [1 ]
Van Brabandt, H. [1 ]
机构
[1] Belgian Hlth Care Knowledge Ctr, Brussels, Belgium
关键词
D O I
10.1016/j.jval.2011.08.121
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A253 / A253
页数:1
相关论文
共 50 条
  • [1] Cost-effectiveness of cardiac resynchronisation therapy for patients with moderate-to-severe heart failure: a lifetime Markov model
    Neyt, Mattias
    Stroobandt, Serge
    Obyn, Caroline
    Camberlin, Cecile
    Devriese, Stephan
    De Laet, Chris
    Van Brabandt, Hans
    BMJ OPEN, 2011, 1 (02):
  • [2] Cost-effectiveness of cardiac resynchronisation therapy in heart failure patients
    Mascioli, G
    Curnis, A
    Bontempi, L
    Bordonali, T
    Dei Cas, L
    Emerging Pathologies in Cardiology, 2005, : 215 - 219
  • [3] Cost-effectiveness of cardiac resynchronization therapy in patients with severe heart failure
    Angel Garcia-Garcia, Miguel
    Angeles Rosero-Arenas, Maria
    Palomo-Navarro, Manuel
    Rosero-Arenas, Esteban
    Maria Valle-Fernandez, Gloria
    Castilla-Rodriguez, Ivan
    INSUFICIENCIA CARDICA, 2015, 10 (01): : 11 - 18
  • [4] Cost-effectiveness of cardiac resynchronisation therapy
    Boriani, Giuseppe
    Diemberger, Igor
    Biffi, Mauro
    Martignani, Cristian
    HEART, 2012, 98 (24) : 1828 - 1836
  • [5] The effect of cardiac resynchronisation therapy on cognitive function in patients with moderate to severe heart failure
    Freeman, C. I.
    McCarthy, R. A.
    Fletcher, L.
    Smith, L. A.
    Kelly, D.
    Cowburn, P. J.
    EUROPEAN HEART JOURNAL, 2015, 36 : 389 - 389
  • [6] Cardiac Resynchronisation Therapy in Patients with Moderate to Severe Heart Failure in Germany: A Cost-Utility Analysis of the Additional Defibrillator
    Moritz Hadwiger
    Fabian-Simon Frielitz
    Nora Eisemann
    Christian Elsner
    Nikolaos Dagres
    Gerhard Hindricks
    Alexander Katalinic
    Applied Health Economics and Health Policy, 2021, 19 : 57 - 68
  • [7] Cardiac Resynchronisation Therapy in Patients with Moderate to Severe Heart Failure in Germany: A Cost-Utility Analysis of the Additional Defibrillator
    Hadwiger, Moritz
    Frielitz, Fabian-Simon
    Eisemann, Nora
    Elsner, Christian
    Dagres, Nikolaos
    Hindricks, Gerhard
    Katalinic, Alexander
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2021, 19 (01) : 57 - 68
  • [8] THE COST-EFFECTIVENESS OF ISOTRETINOIN IN PATIENTS WITH MODERATE-TO-SEVERE ACNE VULGARIS
    Shin, J.
    Hay, J.
    VALUE IN HEALTH, 2010, 13 (03) : A146 - A146
  • [9] The cost-effectiveness of ustekinumab for moderate-to-severe psoriasis
    Rouse, Nicole C.
    Farhangian, Michael E.
    Wehausen, Brooke
    Feldman, Steven R.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2015, 15 (06) : 877 - 884
  • [10] Cost-effectiveness of treatment for moderate-to-severe psoriasis
    Hankin, CS
    Feldman, SR
    Pearce, D
    VALUE IN HEALTH, 2004, 7 (06) : 654 - 654